Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis.
Multiple sclerosis (MS) is characterized by inflammatory demyelination and deposition of fibrinogen in the central nervous system (CNS). Elevated levels of a critical inhibitor of the mammalian fibrinolitic system, plasminogen activator inhibitor 1 (PAI-1) have been demonstrated in human and animal...
Main Authors: | Nicolas Pelisch, Takashi Dan, Atsuhiko Ichimura, Hiroki Sekiguchi, Douglas E Vaughan, Charles van Ypersele de Strihou, Toshio Miyata |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4411110?pdf=render |
Similar Items
-
Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484
by: Machteld Sillen, et al.
Published: (2021-02-01) -
Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity.
by: Veronica R Placencio, et al.
Published: (2015-01-01) -
The contribution of demyelination to axonal loss in multiple sclerosis
by: DeLuca, G, et al.
Published: (2006) -
The contribution of demyelination to axonal loss in multiple sclerosis.
by: DeLuca, G, et al.
Published: (2006) -
Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
by: Coles, A, et al.
Published: (2003)